| Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial J Shapiro, JJB Van Lanschot, MCCM Hulshof, P van Hagen, ... The lancet oncology 16 (9), 1090-1098, 2015 | 2325 | 2015 |
| Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial J Van Hilst, T de Rooij, K Bosscha, DJ Brinkman, S van Dieren, ... The lancet Gastroenterology & hepatology 4 (3), 199-207, 2019 | 521 | 2019 |
| Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial A Cats, EPM Jansen, NCT van Grieken, K Sikorska, P Lind, M Nordsmark, ... The lancet oncology 19 (5), 616-628, 2018 | 474 | 2018 |
| Artificial reporter gene providing MRI contrast based on proton exchange AA Gilad, MT McMahon, P Walczak, PT Winnard Jr, V Raman, ... Nature biotechnology 25 (2), 217-219, 2007 | 456 | 2007 |
| Triple-negative breast cancer: present challenges and new perspectives F Podo, LMC Buydens, H Degani, R Hilhorst, E Klipp, IS Gribbestad, ... Molecular oncology 4 (3), 209-229, 2010 | 399 | 2010 |
| Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial BM Eyck, JJB van Lanschot, MCCM Hulshof, BJ van der Wilk, J Shapiro, ... Journal of Clinical Oncology 39 (18), 1995-2004, 2021 | 371 | 2021 |
| Venous thromboembolism in cancer patients: a population-based cohort study FI Mulder, E Horvàth-Puhó, N van Es, HWM Van Laarhoven, L Pedersen, ... Blood, The Journal of the American Society of Hematology 137 (14), 1959-1969, 2021 | 348 | 2021 |
| Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review JT Hidding, CHG Beurskens, PJ van der Wees, HWM van Laarhoven, ... PloS one 9 (5), e96748, 2014 | 324 | 2014 |
| The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength M Worm-Smeitink, M Gielissen, L Bloot, HWM Van Laarhoven, ... Journal of psychosomatic research 98, 40-46, 2017 | 289 | 2017 |
| Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review LF de Geus-Oei, D Vriens, HWM van Laarhoven, WTA van der Graaf, ... Journal of Nuclear Medicine 50 (Suppl 1), 43S-54S, 2009 | 245 | 2009 |
| The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors JAE Custers, SW van den Berg, HWM van Laarhoven, EMA Bleiker, ... Cancer Nursing 37 (1), E44-E50, 2014 | 240 | 2014 |
| Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study BJ Noordman, MCW Spaander, R Valkema, BPL Wijnhoven, ... The Lancet Oncology 19 (7), 965-974, 2018 | 237 | 2018 |
| Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy IME Desar, CML Van Herpen, HWM Van Laarhoven, JO Barentsz, ... Cancer treatment reviews 35 (4), 309-321, 2009 | 199 | 2009 |
| White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer A Leal, NCT van Grieken, DN Palsgrove, J Phallen, JE Medina, C Hruban, ... Nature communications 11 (1), 525, 2020 | 194 | 2020 |
| Measurement properties of instruments for measuring of lymphedema: systematic review JT Hidding, PB Viehoff, CHG Beurskens, HWM van Laarhoven, ... Physical therapy 96 (12), 1965-1981, 2016 | 186 | 2016 |
| Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO study) MCCM Hulshof, ED Geijsen, T Rozema, V Oppedijk, J Buijsen, KJ Neelis, ... Journal of Clinical Oncology 39 (25), 2816-2824, 2021 | 173 | 2021 |
| Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma EA Ebbing, AP van der Zalm, A Steins, A Creemers, S Hermsen, ... Proceedings of the National Academy of Sciences 116 (6), 2237-2242, 2019 | 163 | 2019 |
| Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: a single-arm phase II feasibility trial (PERFECT) T Van Den Ende, NC De Clercq, MI van Berge Henegouwen, SS Gisbertz, ... Clinical Cancer Research 27 (12), 3351-3359, 2021 | 158 | 2021 |
| Inflammatory breast cancer: an overview DJP Van Uden, HWM Van Laarhoven, AH Westenberg, JHW de Wilt, ... Critical reviews in oncology/hematology 93 (2), 116-126, 2015 | 151 | 2015 |
| Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective K De Joode, DW Dumoulin, V Engelen, HJ Bloemendal, M Verheij, ... European journal of cancer 136, 132-139, 2020 | 150 | 2020 |
